IGF2BP3 and mantle cell lymphoma: At the mRNA level, the proliferation-associated “metagene” signature was higher in patients with a strong expression of IGF2BP3. Although the absolute differences were small, the results fit well with earlier data in mantle cell lymphoma and solid tumors, where the expression of IGF2BP3 was similarly associated with proliferation [7,15].